Compounds > 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione
Page last updated: 2024-09-02

3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Local Neoplasm Recurrence

3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione has been researched along with Local Neoplasm Recurrence in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adcock, LL; Blessing, J; Homesley, HD; Thigpen, JT1
Arsenau, JC; Blessing, J; Lewis, GC; Slavik, M1
Blessing, JA; Homesley, HD; Lewis, GC; Thigpen, JT1
Blessing, JA; Fowler, WC; Hatch, K; Thigpen, JT1

Trials

2 trial(s) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Local Neoplasm Recurrence

ArticleYear
Phase II trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva: a Gynecologic Oncology Group Study.
    Gynecologic oncology, 1986, Volume: 23, Issue:3

    Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Vulvar Neoplasms

1986
Phase II trials of cisplatin and piperazinedione as single agents in the treatment of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Cancer treatment reports, 1986, Volume: 70, Issue:9

    Topics: Carcinoma; Cisplatin; Drug Evaluation; Female; Humans; Neoplasm Recurrence, Local; Piperazines; Uterine Cervical Neoplasms

1986

Other Studies

2 other study(ies) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Local Neoplasm Recurrence

ArticleYear
Phase II trial of piperazinedione (NCS 135758) in the treatment of advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    American journal of clinical oncology, 1983, Volume: 6, Issue:4

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Leukocyte Count; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Thrombocytopenia; Uterine Cervical Neoplasms

1983
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience.
    American journal of clinical oncology, 1982, Volume: 5, Issue:5

    Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Etoposide; Female; Humans; Maytansine; Neoplasm Recurrence, Local; Pelvic Neoplasms; Piperazines; Razoxane; Research Design; Triazines

1982